Abstract
β-lactams are known to cause haematologic reactions. Cefoperazone is one such β-lactam that is commonly combined with a β-lactamase inhibitor, sulbactam. A review of the available literature suggests that cefoperazone can cause or precipitate haematologic reactions, including anaemia, leucopenia, thrombocytopenia and hypoprothrombinemia. Similarly, Escherichia coli (E. coli) is a commonly encountered organism associated with urinary tract infections and urosepsis, which can also present in a similar. This case report is a description of an elderly patient who harboured E. coli, and was also given cefoperazone-sulbactam, and later developed haematologic reactions.
| Original language | English |
|---|---|
| Pages (from-to) | 1884-1886 |
| Number of pages | 3 |
| Journal | Research Journal of Pharmaceutical, Biological and Chemical Sciences |
| Volume | 7 |
| Issue number | 4 |
| Publication status | Published - 01-07-2016 |
All Science Journal Classification (ASJC) codes
- General Biochemistry,Genetics and Molecular Biology
- Pharmacology, Toxicology and Pharmaceutics(all)